CN104845934A - 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 - Google Patents
脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 Download PDFInfo
- Publication number
- CN104845934A CN104845934A CN201510307495.7A CN201510307495A CN104845934A CN 104845934 A CN104845934 A CN 104845934A CN 201510307495 A CN201510307495 A CN 201510307495A CN 104845934 A CN104845934 A CN 104845934A
- Authority
- CN
- China
- Prior art keywords
- cell
- cord blood
- amplification
- substratum
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 title claims abstract description 30
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 title claims abstract description 30
- 210000004700 fetal blood Anatomy 0.000 title claims abstract description 28
- 210000004443 dendritic cell Anatomy 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims description 13
- 210000003958 hematopoietic stem cell Anatomy 0.000 title abstract description 4
- 210000004027 cell Anatomy 0.000 claims abstract description 100
- 239000002243 precursor Substances 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000003321 amplification Effects 0.000 claims abstract description 22
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 22
- 210000005087 mononuclear cell Anatomy 0.000 claims abstract description 15
- 239000011324 bead Substances 0.000 claims abstract description 12
- 108090000978 Interleukin-4 Proteins 0.000 claims abstract description 10
- 230000001939 inductive effect Effects 0.000 claims abstract description 8
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 claims abstract 2
- 210000003995 blood forming stem cell Anatomy 0.000 claims description 24
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 16
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 210000004698 lymphocyte Anatomy 0.000 claims description 13
- 230000000740 bleeding effect Effects 0.000 claims description 12
- 239000000725 suspension Substances 0.000 claims description 12
- 210000001113 umbilicus Anatomy 0.000 claims description 12
- 239000002504 physiological saline solution Substances 0.000 claims description 10
- 238000013016 damping Methods 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000005138 cryopreservation Methods 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 230000004069 differentiation Effects 0.000 claims description 6
- 230000001464 adherent effect Effects 0.000 claims description 5
- 239000006285 cell suspension Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 230000035606 childbirth Effects 0.000 claims description 4
- 230000003394 haemopoietic effect Effects 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000004677 Nylon Substances 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 230000007774 longterm Effects 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 239000011534 wash buffer Substances 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims 1
- 229940087875 leukine Drugs 0.000 claims 1
- 108010038379 sargramostim Proteins 0.000 claims 1
- 239000000427 antigen Substances 0.000 abstract description 11
- 102000036639 antigens Human genes 0.000 abstract description 11
- 108091007433 antigens Proteins 0.000 abstract description 11
- 230000000242 pagocytic effect Effects 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 7
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract description 5
- 239000001963 growth medium Substances 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 3
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 239000011886 peripheral blood Substances 0.000 description 8
- 210000005259 peripheral blood Anatomy 0.000 description 8
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 102100035793 CD83 antigen Human genes 0.000 description 5
- 102000006354 HLA-DR Antigens Human genes 0.000 description 5
- 108010058597 HLA-DR Antigens Proteins 0.000 description 5
- 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 5
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 4
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- -1 CD86 Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 206010036590 Premature baby Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 238000004500 asepsis Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 230000003526 lymphopoietic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 230000006052 T cell proliferation Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940029030 dendritic cell vaccine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 230000005426 magnetic field effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510307495.7A CN104845934B (zh) | 2015-06-08 | 2015-06-08 | 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510307495.7A CN104845934B (zh) | 2015-06-08 | 2015-06-08 | 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104845934A true CN104845934A (zh) | 2015-08-19 |
CN104845934B CN104845934B (zh) | 2018-05-11 |
Family
ID=53845924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510307495.7A Active CN104845934B (zh) | 2015-06-08 | 2015-06-08 | 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104845934B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420192A (zh) * | 2015-10-12 | 2016-03-23 | 王泰华 | 外周血中分离富集造血干细胞的方法 |
CN106011052A (zh) * | 2016-06-15 | 2016-10-12 | 浙江奥比特生物科技有限公司 | 一种高纯度经血来源干细胞的制备方法 |
CN106085960A (zh) * | 2016-07-28 | 2016-11-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种培养dc细胞的培养基及培养方法 |
CN106701682A (zh) * | 2016-11-25 | 2017-05-24 | 博雅干细胞科技有限公司 | 由脐血分离造血干细胞并扩增cd34阳性细胞的方法 |
CN108642013A (zh) * | 2018-05-02 | 2018-10-12 | 中航(宁夏)生物股份有限公司 | 一种从脐带血中分离cd34造血干细胞扩大培养后大规模诱导制备树突状细胞方法 |
CN109207427A (zh) * | 2018-09-17 | 2019-01-15 | 诺未科技(北京)有限公司 | 一种将人造血祖细胞转变为造血干细胞的方法 |
CN113913381A (zh) * | 2021-10-27 | 2022-01-11 | 广州市天河诺亚生物工程有限公司 | 一种造血干细胞分离纯化的方法及其应用 |
CN115011556A (zh) * | 2022-08-10 | 2022-09-06 | 山东省齐鲁干细胞工程有限公司 | 一种脐带血造血干细胞的分离方法 |
CN116426476A (zh) * | 2023-06-08 | 2023-07-14 | 广州正源生物技术有限公司 | 一种脐血dc细胞的培养方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102307989A (zh) * | 2008-11-14 | 2012-01-04 | 生物载体株式会社 | 用于产生树突细胞的方法 |
CN103405759A (zh) * | 2013-07-23 | 2013-11-27 | 蔡建辉 | 一种应用脐血cd34+细胞制备肿瘤特异性dc疫苗方法 |
-
2015
- 2015-06-08 CN CN201510307495.7A patent/CN104845934B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102307989A (zh) * | 2008-11-14 | 2012-01-04 | 生物载体株式会社 | 用于产生树突细胞的方法 |
CN103405759A (zh) * | 2013-07-23 | 2013-11-27 | 蔡建辉 | 一种应用脐血cd34+细胞制备肿瘤特异性dc疫苗方法 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105420192A (zh) * | 2015-10-12 | 2016-03-23 | 王泰华 | 外周血中分离富集造血干细胞的方法 |
CN106011052A (zh) * | 2016-06-15 | 2016-10-12 | 浙江奥比特生物科技有限公司 | 一种高纯度经血来源干细胞的制备方法 |
CN106085960A (zh) * | 2016-07-28 | 2016-11-09 | 广州赛莱拉干细胞科技股份有限公司 | 一种培养dc细胞的培养基及培养方法 |
CN106701682A (zh) * | 2016-11-25 | 2017-05-24 | 博雅干细胞科技有限公司 | 由脐血分离造血干细胞并扩增cd34阳性细胞的方法 |
CN108642013A (zh) * | 2018-05-02 | 2018-10-12 | 中航(宁夏)生物股份有限公司 | 一种从脐带血中分离cd34造血干细胞扩大培养后大规模诱导制备树突状细胞方法 |
CN109207427A (zh) * | 2018-09-17 | 2019-01-15 | 诺未科技(北京)有限公司 | 一种将人造血祖细胞转变为造血干细胞的方法 |
CN113913381A (zh) * | 2021-10-27 | 2022-01-11 | 广州市天河诺亚生物工程有限公司 | 一种造血干细胞分离纯化的方法及其应用 |
CN115011556A (zh) * | 2022-08-10 | 2022-09-06 | 山东省齐鲁干细胞工程有限公司 | 一种脐带血造血干细胞的分离方法 |
CN115011556B (zh) * | 2022-08-10 | 2022-10-25 | 山东省齐鲁干细胞工程有限公司 | 一种脐带血造血干细胞的分离方法 |
CN116426476A (zh) * | 2023-06-08 | 2023-07-14 | 广州正源生物技术有限公司 | 一种脐血dc细胞的培养方法 |
CN116426476B (zh) * | 2023-06-08 | 2023-08-29 | 广州正源生物技术有限公司 | 一种脐血dc细胞的培养方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104845934B (zh) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104845934A (zh) | 脐血cd34+造血干细胞来源树突状细胞的大批量制备方法 | |
CN109628397B (zh) | 一种nk细胞体外扩增培养的方法 | |
CN103597072B (zh) | 单核细胞增殖剂、单核细胞增殖用培养基、单核细胞的制造方法、树突状细胞的制造方法、及树突状细胞疫苗的制造方法 | |
CN107326008A (zh) | 一种从外周血中高效高纯度扩增自然杀伤细胞的方法 | |
AU5436998A (en) | MSC-megakaryocyte precursor composition and method of isolating MSCs asso ciated with isolated megakaryocytes by isolating megakaryocytes | |
CN103301449B (zh) | 一种大规模培养树突状细胞疫苗的制备方法及其应用 | |
CN107299082A (zh) | 从组织中分离胎盘间质细胞并培养成间充质干细胞的方法 | |
CN104498434B (zh) | 一种大量树突状细胞的制备方法、所得树突状细胞 | |
CN110628718A (zh) | 干细胞扩增培养基及干细胞培养方法 | |
CN109161527A (zh) | 一种高效的nk细胞扩增方法 | |
CN102657853A (zh) | 初始t细胞来源的肿瘤特异性杀伤细胞的制备及其应用 | |
CN110564683A (zh) | 一种γδT细胞和NK细胞共培养诱导扩增的方法 | |
CN109825473A (zh) | 一种采用tlr7激动剂刺激的自体外周血淋巴细胞的培养方法 | |
CN108251369B (zh) | 一种免疫细胞培养基、培养方法以及用途 | |
CN111117961B (zh) | 一种肿瘤抗原负载的dc-cik细胞培养方法 | |
JP2014030375A (ja) | 単球またはnk細胞を入手する方法 | |
CN106754704B (zh) | 免疫细胞体外诱导扩增的方法 | |
CN101182488A (zh) | 间充质干细胞的一种新用途 | |
CN113564117A (zh) | 一种冻存脐带血来源调节性t细胞体外扩增优化方法 | |
CN112359016A (zh) | 一种提高中心记忆t细胞比例的t细胞制备技术 | |
CN111690607B (zh) | 一种高效杀伤细胞体外培养试剂盒及培养方法 | |
CN114807031A (zh) | 一种人外周血免疫细胞库和干细胞库的构建方法 | |
CN113564115B (zh) | 一种高扩增型dc-cik细胞及其制备和应用 | |
CN103602634B (zh) | Dc细胞的制备方法及其在制备抗肿瘤细胞制剂中的应用 | |
CN113943704A (zh) | 一种肿瘤新生抗原特异性t细胞的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Cai Jianhui Inventor after: Liu Gang Inventor after: Zhao Shipeng Inventor after: Cai Ying Inventor before: Cai Jianhui Inventor before: Liu Gang Inventor before: Cui Hongjuan Inventor before: Cai Ying |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170328 Address after: 050000 Changjiang Road, high tech Zone, Hebei, Shijiazhuang, China, 238 Applicant after: Hebei Tong Ling Rong Biotechnology Co.,Ltd. Address before: The Yangtze River Road high tech Zone 050000 Hebei province Shijiazhuang Hongchang Science Park No. 238, No. 1 Building 2 layer Applicant before: HEBEI LITONGKANG BIOTECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190402 Address after: Floor 1, Building 1, Hongchang Science Park, 238 Changjiang Avenue, Shijiazhuang High-tech Zone, Hebei Province Patentee after: Shijiazhuang Yote Nong Health Management Co.,Ltd. Address before: 238 Changjiang Avenue, Shijiazhuang High-tech Zone, Hebei Province Patentee before: Hebei Tong Ling Rong Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190705 Address after: 050000 Floor 1, Building 238 Changjiang Avenue, Shijiazhuang High-tech Zone, Hebei Province Patentee after: HEBEI NONGFOYU BIOLOGY TECHNOLOGY Co.,Ltd. Address before: 050000 Floor 1, Building 1, Hongchang Science Park, 238 Changjiang Avenue, Shijiazhuang High-tech Zone, Hebei Province Patentee before: Shijiazhuang Yote Nong Health Management Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211203 Address after: 050000 1st floor, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, high tech Zone, Shijiazhuang, Hebei Patentee after: Nongfuyu pharmaceutical Hebei Co.,Ltd. Address before: 050000 floor 1, building 1, 238 Changjiang Avenue, high tech Zone, Shijiazhuang City, Hebei Province Patentee before: HEBEI NONGFOYU BIOLOGY TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 050000 1st floor, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, high tech Zone, Shijiazhuang, Hebei Patentee after: Nongfuyu pharmaceutical Hebei Co.,Ltd. Address before: 050000 1st floor, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, high tech Zone, Shijiazhuang, Hebei Patentee before: Nongfuyu pharmaceutical Hebei Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231012 Address after: Room 2024, Hebei Publishing Media Creative Center, No. 19 Yuanboyuan Street, Zhengding District, China (Hebei) Free Trade Pilot Zone, Shijiazhuang City, Hebei Province, 050899 Patentee after: Yuetenong biotechnology Hebei Co.,Ltd. Address before: 050000 1st floor, building 1, Hongchang Industrial Park, No. 238 Changjiang Avenue, high tech Zone, Shijiazhuang, Hebei Patentee before: Nongfuyu pharmaceutical Hebei Co.,Ltd. |
|
TR01 | Transfer of patent right |